Professional experience

Anderson Ribeiro has extensive expertise handling cutting-edge litigation and counseling cases in the Life Sciences & Healthcare sector. In addition, he is expert in product recalls, compliance, and anti-corruption matters, focusing on the needs of the health sciences industry. 

He has a distinguished track record in cases involving regulation, government acquisitions, and industrial property before agencies such as the National Health Surveillance Agency (Anvisa), the Ministry of Agriculture (MAPA), and the National Health Agency (ANS), as well as in proceedings before the Federal Audit Court (TCU), the Ministry of Health, the National Institute of Metrology, Quality, and Technology (Inmetro), and state and municipal health departments.  

He represents national and multinational companies from the most varied sectors, with a special focus on biotechnology, pharmaceuticals, health products, food, cosmetics, sanitizing products, pesticides, veterinary products, and emerging technologies.  

 

Education

• Specialist in Regulatory Impact Analysis from LUISS (Italy), 2017;
• LL.M in Intellectual Property from Queen Mary (UK), 2013;
• Master of Laws in Competition Law and Regulation from the University of Lisbon (Portugal) – 2012;
• Bachelor of Laws from the State University of Rio de Janeiro (UERJ), 2005.

 

 

Publications

• Pharma & Medical Device Regulation. Getting the Deal Through, 2020-2021;
• Pharmaceutical IP and competition law in Brazil: overview. Practical Law, 2016-2021;
• Collaboration on Eyeforpharma´s WhitePaper on Access to the Public Health Sector in Brazil (April 2016);
• “The price regulation in Brazil: Roche faces IP rights abuse claims”, Lifesciences Intellectual Property Review, online edition, 2016;
• “The Brazilian Pharmaceutical Sector: A Year in Review”, Life Sciences Intellectual Property Review 2011;
• “Who approves Brazilian Pharma Patents”, World Intellectual Property Review September/October 2010;
• “Impact of the CIS policy on Brazil’s R&D Industry”, Intellectual Property 2010 | Digital Guide;
• “The Misuse of Sham Litigation investigations”, World Intellectual Property Review May/June 2010.

 

Additional Activities

• Member of the Union of Pharmacists of the state of Rio de Janeiro (Sinfar-RJ), and the Union of the Pharmaceutical Products Industry (Sindusfarma);
• Lecturer in the course Access to Medicines and Pharmacoeconomics in the Brazilian Health System at Sindusfarma, 2017 to 2021;
• Latin American Liaison Officer for the IBA Healthcare and Life Sciences Committee.